75 related articles for article (PubMed ID: 22688407)
1. Clinical features of hepatocellular carcinoma in patients with autoimmune hepatitis in Japan.
Ohira H; Abe K; Takahashi A; Zeniya M; Ichida T
J Gastroenterol; 2013 Jan; 48(1):109-14. PubMed ID: 22688407
[TBL] [Abstract][Full Text] [Related]
2. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
Colapietro F; Maisonneuve P; Lytvyak E; Beuers U; Verdonk RC; van der Meer AJ; van Hoek B; Kuiken SD; Brouwer JT; Muratori P; Aghemo A; Carella F; van den Berg AP; Zachou K; Dalekos GN; Di Zeo-Sánchez DE; Robles M; Andrade RJ; Montano-Loza AJ; van den Brand FF; Slooter CD; Macedo G; Liberal R; de Boer YS; Lleo A; ;
J Hepatol; 2024 Jan; 80(1):53-61. PubMed ID: 37802188
[TBL] [Abstract][Full Text] [Related]
3. Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis.
Tansel A; Katz LH; El-Serag HB; Thrift AP; Parepally M; Shakhatreh MH; Kanwal F
Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1207-1217.e4. PubMed ID: 28215616
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.
Tateishi R; Okanoue T; Fujiwara N; Okita K; Kiyosawa K; Omata M; Kumada H; Hayashi N; Koike K
J Gastroenterol; 2015 Mar; 50(3):350-60. PubMed ID: 24929638
[TBL] [Abstract][Full Text] [Related]
5. Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma.
Gerbes A; Zoulim F; Tilg H; Dufour JF; Bruix J; Paradis V; Salem R; Peck-Radosavljevic M; Galle PR; Greten TF; Nault JC; Avila MA
Gut; 2018 Feb; 67(2):380-388. PubMed ID: 29150490
[TBL] [Abstract][Full Text] [Related]
6. Report of the 20th Nationwide follow-up survey of primary liver cancer in Japan.
Kudo M; Izumi N; Kubo S; Kokudo N; Sakamoto M; Shiina S; Tateishi R; Nakashima O; Murakami T; Matsuyama Y; Takahashi A; Miyata H; Takayama T
Hepatol Res; 2020 Jan; 50(1):15-46. PubMed ID: 31655492
[TBL] [Abstract][Full Text] [Related]
7. Report of the 23rd nationwide follow-up survey of primary liver cancer in Japan (2014-2015).
Iijima H; Kudo M; Kubo S; Kurosaki M; Sakamoto M; Shiina S; Tateishi R; Osamu N; Fukumoto T; Matsuyama Y; Murakami T; Takahashi A; Miyata H; Kokudo N
Hepatol Res; 2023 Oct; 53(10):895-959. PubMed ID: 37574758
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in autoimmune hepatitis remains rare.
Grønbæk L; Grønbæk H
J Hepatol; 2024 Jan; 80(1):8-9. PubMed ID: 37821016
[No Abstract] [Full Text] [Related]
9. Questionnaire survey of Japanese board-certified expert hepatobiliary and pancreatic surgeons and instructors on the surgical indications for hepatocellular carcinoma.
Akahoshi K; Shindoh J; Tanabe M; Watanabe S; Takamizawa H; Eguchi S; Endo I; Kubo S; Taketomi A; Nagano H; Nakamura M; Hasegawa K; Hatano E; Yoshizumi T; Kokudo N
J Hepatobiliary Pancreat Sci; 2024 Mar; 31(3):143-151. PubMed ID: 38148501
[TBL] [Abstract][Full Text] [Related]
10. The impact of the COVID-19 pandemic on hepatocellular carcinoma diagnosis and treatment in Japan: A multicenter collaborative observational study.
Murai K; Hikita H; Kodama T; Kaibori M; Nishimura Y; Tatsumi T; Yamada T; Kanto T; Mochida S; Takehara T
Hepatol Res; 2024 May; 54(5):439-450. PubMed ID: 37983632
[TBL] [Abstract][Full Text] [Related]
11. Expanding the Dialogue: A Closer Look at AIH Management and HCC Risk.
Shan D
J Hepatol; 2024 Mar; ():. PubMed ID: 38484914
[No Abstract] [Full Text] [Related]
12. Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort Study.
Chang ML; Le PH; Chen WT; Chen TD; Chien RN
Dig Dis Sci; 2024 Apr; ():. PubMed ID: 38653947
[TBL] [Abstract][Full Text] [Related]
13. Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients.
Tadokoro T; Nomura T; Fujita K; Manabe T; Takuma K; Nakahara M; Oura K; Mimura S; Tani J; Morishita A; Kobara H; Ono M; Masaki T
BMC Gastroenterol; 2024 Apr; 24(1):123. PubMed ID: 38561671
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of serum antinuclear antibodies in patients with autoimmune hepatitis and comorbidity.
Liu H; Wang Y; Wang P; Wang X; Yi Y; Li X
Clin Exp Med; 2023 Nov; 23(7):3453-3463. PubMed ID: 37219793
[TBL] [Abstract][Full Text] [Related]
15. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis.
Wang G; Tanaka A; Zhao H; Jia J; Ma X; Harada K; Wang FS; Wei L; Wang Q; Sun Y; Hong Y; Rao H; Efe C; Lau G; Payawal D; Gani R; Lindor K; Jafri W; Omata M; Sarin SK
Hepatol Int; 2021 Apr; 15(2):223-257. PubMed ID: 33942203
[No Abstract] [Full Text] [Related]
16. Hepatocellular Carcinoma Where You Least Expect It.
Rubin JN; Gilman CAL; Gasmi B; Stern WR; Hernandez JM; Koh C
Am J Gastroenterol; 2020 Jul; 115(7):1134-1136. PubMed ID: 32618667
[No Abstract] [Full Text] [Related]
17. Autoimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies.
Sucher E; Sucher R; Gradistanac T; Brandacher G; Schneeberger S; Berg T
J Immunol Res; 2019; 2019():9437043. PubMed ID: 31886312
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma in patients with autoimmune hepatitis - a systematic review of the literature published between 1989-2016.
Valean S; Acalovschi M; Dumitrascu DL; Ciobanu L; Nagy G; Chira R
Med Pharm Rep; 2019 Apr; 92(2):99-105. PubMed ID: 31086834
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
